Abstract
The success of any vaccine depends on its acceptability. In a prospective cohort study of human papillomavirus vaccine delivery, the bivalent HPV vaccine (Cervarix) was offered to 2817 12- and 13-year-old schoolgirls in Great Britain. The investigators assessed uptake of the first two doses of the three-dose schedule. Almost 71% of girls received the first vaccine dose, and 69% received the second …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
